RHY 1.64% 6.2¢ rhythm biosciences limited

Ann: Update to TGA Submission, page-104

  1. 1,530 Posts.
    lightbulb Created with Sketch. 145
    Yeah it’s painful with the lack of clarity and the time it’s taking. It always portrayed to be imminent but isn’t eventuating. The same presentation over and over again is wearing very thin at this point. They really need to get things rolled out somewhere or the SP will keep drifting lower on no news with a potential resubmission/outcome push out so far.

    I’ve experienced this with other companies - tech and bio - an it’s just a painful wait usually. Look at MSB - thank god I wasn’t in the mess. I really do they they need to get FDA underway as well. It will be required down the road.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.